期刊文献+

扩散加权成像在评估宫颈癌预后中的应用现状

Application of magnetic resonance diffusion-weighted imaging in cervical cancer
在线阅读 下载PDF
导出
摘要 磁共振扩散加权成像(DWI)作为一种无创性功能影像检查,可从分子水平研究疾病,从而达到监测病灶细胞密度和微循环改变的目的,目前已广泛应用于宫颈癌的诊断。随着DWI技术的发展,其在宫颈癌中的应用价值逐步增多。Ki-67反映肿瘤细胞增殖速率,血管内皮生长因子(VEGF)在恶性肿瘤患者中明显升高,两者在宫颈癌的发生发展中均具有重要意义,是宫颈癌重要的预后相关因素。通过DWI检查测量表观扩散系数(ADC)可一定程度反映Ki-67及VEGF水平,从而无创的预测宫颈癌的疾病转归情况,或将成为DWI的新应用热点。 Diffusion-weighted magnetic resonance imaging(DWI),as a non-invasive functional imaging examination,can study the disease at the molecular level,so as to achieve the purpose of monitoring the changes of cell density and microcirculation in the lesion.It has been widely used in the diagnosis of cervical cancer.With the development of DWI technology,its application value in cervical cancer increases gradually.Ki-67 reflects the proliferation rate of tumor cells,and vascular endothelial growth factor(VEGF)is significantly increased in patients with malignant tumors,both of which have important significance in the occurrence and development of cervical cancer and are important prognostic factors of cervical cancer.The apparent diffusion coefficient(ADC)measured by DWI can reflect Ki-67 and VEGF levels to a certain extent,so as to predict the disease outcome of cervical cancer non-invitingly,which may become a new hotspot of DWI application.
作者 刘丽秋 张继 LIU Li-qiu;ZHANG Ji(Graduate School,Dalian Medical University,Dalian 116044,Liaoning,CHINA;Department of Imaging,Taizhou People's Hospital,Taizhou 225300,Jiangsu,CHINA)
出处 《海南医学》 CAS 2021年第11期1476-1479,共4页 Hainan Medical Journal
基金 江苏省青年医学人才课题(编号:QNRC2016509) 江苏省高层次卫生人才“六个一工程”拔尖人才科研项目(编号:LGY2018032)。
关键词 磁共振扩散加权成像 表观扩散系数 宫颈癌 KI-67 血管内皮生长因子 Diffusion-weighted imaging(DWI) Apparent diffusion coefficient(ADC) Cervical cancer Ki-67 Vascular endothelial growth factor(VEGF)
  • 相关文献

参考文献8

二级参考文献63

  • 1宫颈癌及癌前病变规范化诊疗指南(试行)[J].中国医学前沿杂志(电子版),2013,5(8):40-49. 被引量:261
  • 2单军,徐坚民,龚静山,王晓玫,徐宏里,冯晓凤.早期增强MRI对良恶性卵巢肿瘤的鉴别诊断价值[J].中华放射学杂志,2003,37(11):1001-1006. 被引量:41
  • 3刘妍,夏黎明,邹明丽,王承缘.磁共振扩散加权成像及ADC值测量在淋巴结病变鉴别诊断中的价值[J].中国医学影像技术,2006,22(5):730-732. 被引量:47
  • 4Halamkova J,Kiss I,Pavlovsky Z,et al.Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients[J].Neoplasma,2011,58 (5):377-385.
  • 5Kogianni G,Walker M M,Waxman J,et al.Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression[J].Eur J Cancer,2009,45(4):685-693.
  • 6Kimura H,Li X,Torii K,et al.Glucocorticoid enhances hypoxia-and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells[J].Clin Exp Ncphrol,2011,15 (1):34-40.
  • 7Jach R,Dulinska-litewka J,Laidler P,et al.Expression of VEGF,VEGF-C and VEGFR-2 in in situ and invasive SCC of cervix[J].Front Biosci,2010,2 (1):411-423.
  • 8Cheng W F,Chen C A,Lee C N,et al.Vascular endothelial growth factor in cervical carcinoma[J].Obstet Gynecol,1999,93(5 Pt 1):761-765.
  • 9Patrick Z. McVeigh,Aejaz M. Syed,Michael Milosevic,Anthony Fyles,Masoom A. Haider.Diffusion-weighted MRI in cervical cancer[J].European Radiology.2008(5)
  • 10Tsuyoshi Komori,Isamu Narabayashi,Kaname Matsumura,Mitsuru Matsuki,Hiroyuki Akagi,Yasuharu Ogura,Fumitoshi Aga,Itaru Adachi.2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience[J].Annals of Nuclear Medicine.2007(4)

共引文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部